1. Home
  2. TCRT vs POAS Comparison

TCRT vs POAS Comparison

Compare TCRT & POAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alaunos Therapeutics Inc.

TCRT

Alaunos Therapeutics Inc.

N/A

Current Price

$0.92

Market Cap

2.4M

Sector

Health Care

ML Signal

N/A

Logo Phaos Technology Holdings (Cayman) Limited Class A Ordinary Shares

POAS

Phaos Technology Holdings (Cayman) Limited Class A Ordinary Shares

N/A

Current Price

$0.18

Market Cap

2.8M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
TCRT
POAS
Founded
1998
2017
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.4M
2.8M
IPO Year
2025
2024

Fundamental Metrics

Financial Performance
Metric
TCRT
POAS
Price
$0.92
$0.18
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 382.8K
102.7K
Earning Date
11-13-2026
11-21-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 24.66
N/A
EPS
N/A
★ N/A
Revenue
★ $15,900,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.95
$0.15
52 Week High
$4.57
$7.40

Technical Indicators

Market Signals
Indicator
TCRT
POAS
Relative Strength Index (RSI) 31.10 39.49
Support Level N/A $0.15
Resistance Level $2.09 $0.18
Average True Range (ATR) 0.17 0.01
MACD -0.03 0.00
Stochastic Oscillator 8.18 26.92

Price Performance

Historical Comparison
TCRT
POAS

About TCRT Alaunos Therapeutics Inc.

Alaunos Therapeutics Inc is a preclinical-stage biopharmaceutical company focused on the development of novel, orally administered small-molecule therapeutics for obesity and related metabolic disorders, such as metabolic dysfunction-associated steatotic liver disease (MASLD, a type of fatty liver disease). The program aims to develop a differentiated, non-hormonal, non-incretin approach, unlike hormone-based treatments like GLP-1 drugs. It has a single reportable and operating segment related to biopharmaceutical research and development.

About POAS Phaos Technology Holdings (Cayman) Limited Class A Ordinary Shares

Phaos Technology Holdings Cayman Ltd is an investment holding company incorporated in the Cayman Islands. Through its subsidiaries, the Company engages in the research, development, manufacturing, and commercialization of optical technologies and products. Leveraging its patented microsphere technology, Phaos enhances the magnification of traditional optical microscopes, enabling visualization beyond the 200nm optical limit at a commercially viable working distance. The Company offers high tech microscopy equipment and parts, along with AI-powered software solutions that complement its hardware to deliver fully integrated microscopy systems. Its technologies serve diverse sectors, including manufacturing, biomedical, and research.

Share on Social Networks: